Carasent

AGM Information • Oct 4, 2024

Carasent ASA Extraordinary general meeting has approved cross-border merger to effect relisting to Nasdaq Stockholm

Carasent ASA Extraordinary general meeting has approved cross-border merger to effect relisting to Nasdaq Stockholm

Reference is made to Carasent AS s ("Carasent" or the "Company") stock

exchange and press release 30 August 2024 regarding the merger plan for a

cross-border merger to the effect that shareholders will have their Carasent

shares one for one exchanged with Carasent SWE shares listed only on Nasdaq

Stockholm (the "Relisting") and to the calling notice 10 September 2024 for an

extraordinary general meeting to resolve on the proposed cross-border merger

to be held today.

The extraordinary general meeting has been held today. The cross-border merger

was approved.

Please find attached the minutes with attachments from today's extraordinary

general meeting in Carasent ASA ("Carasent").

The cross-border merger and Relisting are estimated to be completed during

December 2024.

Further information on key dates etc. will follow. The cross-border merger

remains subject to conditions precedent, inter alia, obtaining relevant

approvals from Nasdaq Stockholm and relevant governmental authorities.

For further information, please contact:

Petri Nemi, Chairman of the Board Tel: +358 40 051 149

This information is subject to disclosure under the Norwegian Securities

Trading Act, §5-12. The information was submitted for publication at

2024-10-04 09:30 CEST.